menu
    • menu

    Company profile for Lattice Biologics

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lattice Biologics Ltd. is an emerging leader in the field of cellular therapies and tissue engineering. Lattice develops and processes biologic allograft products for domestic and international markets. Lattice’s allograft products are used in a variety of clinical applications, including: Enhancing fusion in spine surgery Enhancing breast reconstruction post mastectomy for breast cancer patients Sports medicine indi...
    Lattice Biologics Ltd. is an emerging leader in the field of cellular therapies and tissue engineering. Lattice develops and processes biologic allograft products for domestic and international markets. Lattice’s allograft products are used in a variety of clinical applications, including: Enhancing fusion in spine surgery Enhancing breast reconstruction post mastectomy for breast cancer patients Sports medicine indications, including ACL repair Promotion of bone regeneration in foot and ankle surgery

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lattice BiologicsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Lattice Biologics Ltd. 512 E Madison Ave. Suite 101 Belgrade, MT 59714
    Telephone
    Telephone
    +1.406-570-2658
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.latticebiologics.com/
    Linkedin
    Linkedin
    https://linkedin.com/Lattice-Biologics-Inc
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/latticebio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lattice Biologics Ltd. Reports Second Quarter 2021 Results and Resumes Trading
    Lattice Biologics Ltd. Reports Second Quarter 2021 Results and Resumes Trading

    09 Jul 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210709005421/en

    BUSINESSWIRE
    09 Jul 2021
    Share Share
    Lattice Biologics Reorganizes to Focus on Psychedelics and Cannabis Therapies
    Lattice Biologics Reorganizes to Focus on Psychedelics and Cannabis Therapies

    15 Mar 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210315005261/en/Lattice-Biologics-Reorganizes-to-Focus-on-Psychedelics-and-Cannabis-Therapies

    BUSINESSWIRE
    15 Mar 2021
    Share Share
    COVID19 UPDATE – Lattice Biologics Announces Cessation of Patient Recruitment
    COVID19 UPDATE – Lattice Biologics Announces Cessation of Patient Recruitment

    03 Sep 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200902005975/en/COVID19-UPDATE-%E2%80%93-Lattice-Biologics-Announces-Cessation

    BUSINESSWIRE
    03 Sep 2020
    Share Share
    Lattice Biologics Eliminates CAN$838,000 in Debt
    Lattice Biologics Eliminates CAN$838,000 in Debt

    08 Jun 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200608005775/en/Lattice-Biologics-Eliminates-CAN838000-Debt#:~:text=BELGRADE%2C%20Mont.%2D%2D(BUSINESS%20WIRE,Company%20to%20settle%20outstanding%20debt.

    BUSINESSWIRE
    08 Jun 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search